Galectin-7: Will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?

Histology and Histopathology

Volumn 24, Issue 1, 2009, Pages 41-48

  Cada, Z ^a   Chovanec, Martin ^a,b   Smetana Jr , K ^a,b   Betka, J ^a   Lacina, L ^a   Plzek, J ^a,b   Kodet, R ^b   Stork J ^a   Lensch, M ^c   Kaltner, H ^c   Andre S ^c   Gabius, H J ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Carcinoma; Collagen IV; Galectin; Keratinization; Lectin; LectinCarcinoma

Indexed keywords

COLLAGEN TYPE 4; CYTOKERATIN 10; CYTOKERATIN 14; GALECTIN 7; KI 67 ANTIGEN; LECTIN; GALECTIN; LGALS7 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; LYMPH NODE METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; BIOSYNTHESIS; CELL DIFFERENTIATION; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PATHOLOGY;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; COLLAGEN TYPE IV; FEMALE; GALECTINS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KERATIN-14; KI-67 ANTIGEN; MALE; NEOPLASM STAGING;

EID: 60549112880     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. André S., Kaltner H., Furuike T., Nishimura S.I. and Gabius H.J. (2004). Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjugate Chem. 15, 87-98.
2. André S., Kolár T., Schuberth R., Unverzagt C., Kojima S. and Gabius H.J. (2007a). Substitutions in the N glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties. Biochemistry 46, 6984-6995.
3. INK4a- modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 274, 3233-3256.
4. Bernerd F., Sarasin A. and Magnaldo T. (1999). Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc. Natl. Acad. Sci. USA 96, 11329-11334.
5. Bryne M., Koppang H.S., Lilleng R., Stene T., Bang G. and Dabelsteen E. (1989). New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J. Oral. Pathol. Med. 18, 432-437.
6. Chen J., He Q.Y., Yuen A.P.W. and Chiu J.F. (2004). Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4, 2465-2475.
7. Chovanec M., Smetana K. Jr., Plzák J., Betka J., Plzáková Z.,. Štork J., Hrdličková E., Kuwabara I., Dvořánková B., Liu F.T., Kaltner H., André S. and Gabius H.J. (2005). Detection of new diagnostic markers in pathology by focus on growth-regulatory endogenous lectins. The case study of galectin-7 in squamous epithelia. Prague Med. Rep. 106, 209-216.
8. Cooper D.N.W. (2002). Galectinomics: finding themes in complexity. Biochim. Biophys. Acta 1572, 209-231.
9. Demers Ḿ., Biron-Pain K., Hébert J., Lamarre A., Magnaldo T. and StPierre Y. (2007). Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model. Cancer Res. 67, 2824-2829.
10. Dvořánková B., Smetana K. Jr., Chovanec M., Lacina L., Štork J., Plzáková Z., Galovičová M. and Gabius H.J. (2005). Transient expression of keratin K19 is induced in originally negative interfollicular epidermal cells by adhesion of suspended cells. Int. J. Mol. Med. 16: 525-531.
11. Dvořánková B., Lacina L., Smetana K. Jr., Lensch M., Manning J.C., André S. and Gabius H.J. (2008). Human galectin-2: nuclear presence in vitro and its modulation by quiescence/ stress factors. Histol. Histopathol. 23, 167-178.
12. Gabius H.J. (1997a). Concepts of tumor lectinology. Cancer. Invest. 15, 454-464.
13. Gabius H.J. (1997b). Animal lectins. Eur. J. Biochem. 243, 543-576.
14. Gabius H.J. (2006). Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit. Rev. Immunol. 26, 43-79.
15. Holíková Z., Hrdličková-Cela E., Plzák J., Smetana K. Jr., Betka J., Dvořánková B., Esner M., Wasano K., André S., Kaltner H., Motlík J., Hercogová J., Kodet R. and Gabius H.-J. (2002). Defining the glycophenotype of squamous epithelia by plant and mammalian lectins. Differentiation-dependent expression of ·2,6- and ·2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas and its differential effect on binding of the endogenous lectins galectins-1 and -3. APMIS. 110, 845-856.
16. Kasai K.I. and Hirabayashi J. (1996). Galectins: a family of animal lectins that decipher glycocodes. J. Biochem. 119, 1-8.
17. Kayser K., Hoeft D., Hufnagl P., Caselitz J., Zick Y., André S., Kaltner H. and Gabius H.J. (2003). Combined analysis of tumor growth pattern and expression of endogenous lectins as prognostic tool in primary testicular cancer and its lung metastases. Histol. Histopathol. 18, 771-779.
18. Kopitz J., André S., von Reitzenstein C., Versluis K., Kaltner H., Pieters R.J., Wasano K., Kuwabara I., Liu F.T., Cantz M., Heck A.J.R. and Gabius H.J. (2003). Homodimeric galectin-7 (p53 induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22, 6277-6288.
19. Langbein S., Brade J., Badawi J.K., Hatzinger M., Kaltner H., Lensch M., Specht K., André S., Brinck U., Alken P. and Gabius H.J. (2007). Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 51, 681-690.
20. Lohr M., Lensch M., André S., Kaltner H., Siebert H.C., Smetana K. Jr., Sinowatz F. and Gabius H.J. (2007). Murine homodimeric adhesion/ growth-regulatory galectins-1, -2, and -7: comparative profiling of gene/ promoter sequences by database mining, of expression by RT-PCR/ immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry. Folia Biol. (Praha). 53, 109-128.
21. Lu J., Pei H., Kaeck M. and Thompson H.J. (1997). Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol. Carcinogen. 20, 204-215.
22. Madsen P., Rasmussen H., Flint T., Gromov P., Kruse A., Honore B., Vorum H. and Celis J. (1995). Cloning, expression, and chromosome mapping of human galectin-7. J. Biol. Chem. 270, 5823-5829.
23. Magnaldo T., Bernerd F. and Darmon M. (1995). Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev. Biol. 168, 259-271.
24. Magnaldo T., Fowlis D. and Darmon M. (1998) Galectin-7, a marker of all types of stratified epithelia. Differentiation 63, 159-168.
25. Moisa A., Fritz P., Eck A., Wehner H.D., Mürdter T., Simon W. and Gabius H.J. (2007). Growth/adhesion-regulatory tissue lectin galectin-3: stromal presence but not cytoplasmic/nuclear expression in tumor cells as negative prognostic factor in breast cancer. Anticancer Res. 27, 2131-2140.
26. Moisan S., Demers M., Mercier J., Magnaldo T., Potworowski E.F. and St-Pierre Y. (2003). Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia 17, 751-759.
27. Østergaard M., Rasmussen H.H., Nielsen H.V., Vorum H., Ørntoft T.F., Wolf H. and Celis J.E. (1997). Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res. 57, 4111-4117.
28. Plzák J., Smetana K. Jr., Hrdliäková E., Kodet R., Holíková Z., Liu F.T, Dvofiánková B., Kaltner H., Betka J. and Gabius H.J. (2001). Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int. J. Oncol. 19, 59-64.
29. Polyak K., Xia Y., Zweier J.L., Kinzler K.W. and Vogelstein B. (1997). A model for p53-induced apoptosis. Nature 389, 300-305.
30. Ravasz L.A., Hordijk G.J., Slootweg P.J., Smit F. and Tweel I.V. (1993). Uni- and multivariate analysis of eight indications for post-operative radiotherapy and their significance for local-regional cure in advanced head and neck cancer: J. Laryngol. Otol. 107, 437-440.
31. Rorive S., Eddafali B., Fernandez S., Decaestecker C., André S., Kaltner H., Kuwabara I., Liu F.T., Gabius H.J., Kiss R. and Salmon I. (2002). Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod. Pathol. 15, 1294-1301.
32. Rotblat B., Niv H., André S., Kaltner H., Gabius H.J. and Kloog Y. (2004). Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res. 64, 3112-3118.
33. Saussez S., Cucu D.R., Decaestecker C., Chevalier D., Kaltner H., André S., Wacreniez A., Toubeau G., Camby I., Gabius H.J. and Kiss R. (2006). Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann. Surg. Oncol. 13, 999-1009.
34. Saussez S. and Kiss R. (2006). Galectin-7. Cell. Mol. Life Sci. 63, 687-697.
35. Saussez S., Lorfevre F., Decaestecker C., Chevalier D., Kaltner H., André S., Toubeau G., Gabius H.J. and Leroy X. (2008). Increased expression and altered intracellular distribution of adhesion/ growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 52, 483-493.
36. Smetana K. Jr., Dvofiánkov B., Chovanec M., Bouãek J., Klíma J., Motlík J., Lensch M., Kaltner H., André S. and Gabius H.J. (2005). Nuclear presence of adhesion/ growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem. Cell Biol. 125, 171-182.
37. Sturm A., Lensch M., André S., Kaltner H., Wiedenmann B., Rosewicz S., Dignass A.U. and Gabius H.J. (2004). Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J. Immunol. 173, 3825-3837.
38. Villalobo A., Nogales-González A. and Gabius H.J. (2006). A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci. Glycotechnol. 18, 1-37.
39. Wang J.L., Gray R.M., Haudek K.C. and Patterson R.J. (2004). Nucleocytoplasmic lectins. Biochim. Biophys. Acta 1673, 75-93.
40. Wu A.M., Singh T., Wu J.H., Lensch M., André S. and Gabius H.J. (2006). Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. Glycobiology 16, 524-537.